https://orcid.org/0000-0002-8537-0195
References
- Zoulim F , LebosseF, LevreroM. Current treatments for chronic hepatitis B virus infections. Curr. Opin. Virol.18, 109–116 (2016).
- Gua R , LuiHF. Treatment of hepatitis B in decompensated liver cirrhosis. Int. J. Hepatol.2011, 1–11 (2011).
- do Carmo RF , VasconcelosLRS, MendonçaTF, doSocorro de Mendonça Cavalcanti M, BeltrãoPereira LMM, MouraP. Myeloperoxidase gene polymorphism predicts fibrosis severity in women with hepatitis C. Hum. Immunol.75(8), 766–770 (2014).
- Alavian SM , ShowrakiA. Hepatitis B and its relationship with oxidative stress. Hepat. Mon.16(9), e37973 (2016).
- Namiduru ES , NamiduruM, TarakçioğluM, TanriverdiM. Levels of malondialdehyde, myeloperoxidase and nitrotyrosine in patients with chronic viral hepatitis B and C. Adv. Clin. Exp. Med.21(1), 47–53 (2012).
- Cai Z , YanLJ. Protein oxidative modifications: beneficial roles in disease and health. J. Biochem. Pharmacol. Res.1(1), 15–26 (2013).
- Piciocchi M , CardinR, CilloUet al. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. Transl. Res.168, 122–133 (2016).
- Harmandar FA , HarmandarIO, TezelIA. Diagnostic and predictive values of serum and acid fluid TNF-alpha, interleukin-6, nitric oxide, and myeloperoxidase in patients with neutrocytic acid cirrhosis. Turk. J. Acad. Gastroenterol.19, 75–82 (2020).
- European Association for the Study of the Liver . Clinical practice guidelines on the management of hepatitis B virus infection (2017). www.easl.eu/medias/cpg/management-of-hepatitis-B-virus-infection/English-report.pdf
- Ishak K , BaptistaA, BianchiLet al. Histological grading and staging of chronic hepatitis. J. Hepatol.22(6), 696–699 (1995).
- Tang J , YanZ, FengQet al. The roles of neutrophils in the pathogenesis of liver diseases. Front. Immunol.12, 1–11 (2021).
- Seckin Y , CaginYF, SenerF. Is myeloperoxidase level in ascites a predictive factor for spontaneous bacterial peritonitis?J. Turgut Ozal Med. Cent.23(2), 146–151 (2016).
- Peterhans E . Sendai virus stimulates chemiluminescence in mouse spleen cells. Biochem. Biophys. Res. Commun.91, 383–392 (1979).
- Fujita N , HoriikeS, SugimotoR, HideakiT, IwasaM. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic. Biol. Med.42(3), 353–362 (2007).
- Fisgin NT , AydinBK, SarikayaHet al. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin. Lab.58(3–4), 273–280 (2012).
- Lozano-Sepulveda SA , Bryan-MarrugoOL, Cordova-FletesC, Gutierrez-RuizMC, Rivas-EstillaAM. Oxidative stress modulation in hepatitis C virus infected cells. World J. Hepatol.7(29), 2880–2889 (2015).
- Kothari N , KeshariRS, BograJet al. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J. Crit. Care26(4), 1–7 (2010).
- Kaffe ET , RigopoulouEI, KoukoulisGK, DalekosGN, MoulasAN. Oxidative stress and antioxidant status in patients with autoimmune liver diseases. Redox Rep.20(1), 33–41 (2015).
- Mohamadkhani A , JaziiFR, SayehmiriKet al. Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients. Arch. Iran. Med.14(4), 254–258 (2011).
- Güler SA , TolunFI, UcmakH, HaskayaG, YavuzM. Relationship between antioxidant capacity and oxidative stress in patients with chronic hepatitis B. Adv. Lab. Med. Int.4(1), 17–25 (2014).
- Nakamuta M , OhashiM, TanabeY, HiroshigeK, NawataH. High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism. Hepatology18(6), 1377–1383 (1993).
- Bekheet IW , MadkourME, GhaffarNAet al. The role of myeloperoxidase in hepatitis C virus infection and associated liver cirrhosis. Open Trop. Med. J.2, 1–7 (2009).
- do Carmo RF , de AlmeidaDB, LinsAroucha DCBet al. Plasma myeloperoxidase levels correlate with hepatocellular carcinoma in chronic hepatitis C. Hum. Immunol.73(11), 1127–1131 (2012).